Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Rebtech Novel Material
Hangzhou, Zhejiang, Chinahzrebtech.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Hangzhou Rebtech provides a range of cosmetic and pharmaceutical raw materials, including innovative small molecules and peptides for skin care and health applications, with commercial scale supply for domestic and global markets
- Therapeutic areas
- OphthalmologyDermatologyCardiovascular
- Modalities
- Small moleculePeptidesBiologicNanoparticle (e.g., gold nanorods)ProteinVitamin derivativesAmino compound derivatives
- Industry
- Chemicals & Materials
02
Partnerships
Collaboration with Zhejiang University of Technology for R&DDistributors in Asia, Europe, AmericaWell-known formulation companies in Europe and America
Beyond the preview
Go deeper on Hangzhou Rebtech Novel Material.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hangzhou Rebtech Novel Material.